Navigation Links
Cell Therapeutics, Inc. (CTI) President Craig Philips to Present at Invest Northwest

SEATTLE, March 17 /PRNewswire-FirstCall/ -- Craig Philips, President of Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) will present at the 8th Annual WBBA Invest Northwest Conference on Wednesday, March 18th at 10:10 AM in the Harbor Dining Room of the Bell Harbor Conference Center.

Philips was named President of CTI in August of 2008. Prior to CTI, Philips was Vice President and General Manager of Bayer Healthcare Oncology, with direct responsibilities for all Development and Commercial Operations. Starting in 2006 Philips led Bayer's U.S. oncology operations, following the integration of the U.S. oncology businesses from Berlex and Bayer. He oversaw the U.S. oncology operations, with sales of $350 million and a staff of over 150. Prior to Bayer, Philips was the head of Berlex Oncology as Vice President and General Manager at Berlex Oncology. He was responsible for the U.S. oncology operations with sales of over $160 million. Prior to Berlex, Philips was with Schering Plough in U.S., global, and international roles. He began his career with Bristol Myers, where he worked in a variety of therapy areas including oncology, cardiology, and CNS.

The presentation will also be webcast live with slides, and available for replay after the presentation. The webcast can be accessed at

                       WBBA Invest Northwest Conference
                 CTI Presentation: Wednesday, March 18, 2009
                     10:10 AM PST/1:10 PM EST/6:10 PM CET
              Harbor Dining Room, Bell Harbor Conference Center
            Audio webcast with slides at

     Media Contact:
     Dan Eramian
     T: 206.272.4343
     C: 206.854.1200

     Investors Contact:
     Ed Bell
     T: 206.282.7100
     Lindsey Jesch Logan
     T: 206.272.4347
     F: 206.272.4434

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cell Therapeutics, Inc. to Offer to Repurchase up to $124 Million of Its Notes
2. Nile Therapeutics, Inc. Reports 2008 Third Quarter Financial Results
3. Cell Therapeutics, Inc. (CTI) Rodman & Renshaw Healthcare Conference Presentation to be Webcast
4. Cell Therapeutics, Inc. (CTI) Oppenheimer & Co. Healthcare Conference Presentation to be Webcast
5. Cornerstone Therapeutics, Inc. Taps Josh Franklin to Head Marketing Team
6. Cell Therapeutics, Inc. Announces Single Institutional Investor to Purchase Up to $18 Million of Senior Convertible Notes
7. Cell Therapeutics, Inc. Announces $12 Million Equity Line of Credit
8. Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
9. Zevalin Revenues Lead Cell Therapeutics, Inc.s First Quarter 2008 Financial Results
10. Juvaris BioTherapeutics, Inc. Announces the Appointment of Grant E. Pickering as Chief Executive Officer
11. Cell Therapeutics, Inc. (CTI) Reports Recent Accomplishments and 2007 Fourth Quarter and Year End Financial Results
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
(Date:11/25/2015)... ... November 25, 2015 , ... In ... nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care for pulmonary hypertension ... Pioneers, nominated by the public, will receive special recognition throughout 2016 as part ...
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... lower prices in an early celebration of the early holiday shopping season. Starting ... $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in addition to ...
(Date:11/24/2015)... Mississauga, ON (PRWEB) , ... November 24, 2015 , ... ... Deborah Williams without a referral for dental implants at her Mississauga, ON ... qualified and experienced in the placement of dental implants. , Missing teeth can ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... LYON , Frankreich, November 25, 2015 ... hat heute bekanntgegeben, dass sie eine Lizenz für das ... Inserm, Poxel, CNRS, UCBL und ENS-Lyon innehaben, an Enyo ... 2009 von FUI AAP8 ins Leben gerufenen und von ... NATHEB-Programms wurde FXR als ein Behandlungsziel für HBV identifiziert, ...
(Date:11/24/2015)... Nov. 24, 2015  Natera, Inc. (Nasdaq: ... genetic testing and the analysis of circulating ... present at the 27 th  Annual Piper ... 2015 at 1:00 p.m. ET.  Matthew Rabinowitz, Ph.D., CEO of ... business activities and financial outlook. ...
(Date:11/24/2015)... , 24. November 2015 Avery ... Pacemaker Systems, ist erfreut, die Berufung von ... bekannt geben zu können. ... --> Foto - ... (Schweden). Von 1984-1986 war er Fellow des ...
Breaking Medicine Technology: